Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer

Citation
Je. Trosko et Cc. Chang, Mechanism of up-regulated gap junctional intercellular communication during chemoprevention and chemotherapy of cancer, MUT RES-F M, 480, 2001, pp. 219-229
Citations number
91
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
ISSN journal
13861964 → ACNP
Volume
480
Year of publication
2001
Pages
219 - 229
Database
ISI
SICI code
1386-1964(20010901)480:<219:MOUGJI>2.0.ZU;2-#
Abstract
To develop a strategy for efficacious intervention in order to prevent or t reat various cancers, one must understand the basic mechanism(s) by which v arious anticancer dietary factors prevent or reverse the tumor promotion or progression phases. Carcinogenesis is a multistage, multimechanism process , involving the irreversible alteration of a stem cell (the "initiation" ph ase), followed by the clonal proliferation of the initiated stem cell (the "promotion" phase), from which the acquisition of the invasive and metastat ic phenotypes are generated (the "progression" phase). While intervention t o prevent or treat cancer could occur at each step, the objective of this p resentation will focus on the rate limiting step, the promotion phase. Gap junctional intercellular communication (GJIC) has been hypothesized to regulate growth control, differentiation and apoptosis. Most normal, contac t-inhibited cells have functional GJIC, while most, if not all, tumor cells have dysfunctional homologous or heterologous GJIC. Cancer cells are chara cterized by the lack of growth control, by the inability to terminally diff erentiate and by resistance to apoptosis. Chemical tumor promoters (phorbol esters. DDT, phenobarbital, unsaturated fatty acids, saccharin, etc.) inhi bit GJIC in a reversible fashion and at doses above particular chemical thr esholds. Various oncogenes (e.g. ras, raf neu, src, mos) down-regulate GJIC while several tumor suppressor genes can up-regulate GJIC. Antitumor promo ters (retinoids, carotenoids, green tea components) and antioncogene drugs (i.e. lovastatin) can up-regulate GJIC. Transfection of gap junction genes ("connexins") into GJIC-deficient tumor cells can restore GJIC, growth cont rol and reduce tumorigenicity. On the other hand, antisense gap junction ge nes can convert the phenotype of a non-tumorigenic cell to that of a tumori genic one. Recently, a specific connexin knockout mouse was shown to have a higher frequency of spontaneous and induced liver cancers. Evidence from these studies clearly suggests that dietary factors can modul ate GJIC by inducing various signal transducing systems. The modulation can either down-regulate GJIC and lead to tumor promotion or it can up-regulat e GJIC and lead to suppression of the initiated cells. Multiple mechanisms of up- or down-regulation of GJIC exist, as well as multiple types of pre-m alignant and malignant tumor cells that are unable able to have functional GJIC. GJIC can be down-regulated by mutations and by epigenetic means. Alte ration of gene expression at the transcriptional, translational or post-tra nslational levels would require specific dietary prevention or treatment of cancer. In conclusion, if dietary prevention or treatment of cancer is to occur, it must ameliorate the growth-stimulatory effects, above threshold l evels, of chemicals, growth factors or hormones. that trigger various mitog enic/antiapoptotic signal transducing systems that block GJIC. (C) 2001 Els evier Science B.V. All rights reserved.